2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Coccidioidomycosis: new trials by email Literature Review of Coccidioidomycosis trials Research Report on Coccidioidomycosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole SUBA itraconazole, Conventional itraconazole - Invasive Fungal Infections | Phase 2 / Phase 3 | Completed | University of Alabama at Birmingham | 88 | 2018-09-17 | 2023-07-07 |
| Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options Olorofim - Invasive Fungal Infections | Phase 2 | Completed | F2G Biotech GmbH | 203 | 2018-06-06 | 2024-07-10 |
Invasive Fungal Infections (2) · Blastomycosis (1) · Histoplasmosis (1)
Bacterial Infections and Mycoses (2) · Infections (2) · Mycoses (2) · Dermatomycoses (1) · Lung Diseases (1) · Lung Diseases, Fungal (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin and Connective Tissue Diseases (1)
Itraconazole (1) · olorofim (1)
F2G Biotech GmbH (1) · University of Alabama at Birmingham (1)
United States (2) · Australia (1) · Belgium (1) · Brazil (1) · Egypt (1) · France (1) · Germany (1) · Israel (1) · Netherlands (1) · Panama (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Thailand (1)
Andrej Spec, MD (1) · George R Thompson, MD (1) · Peter G Pappas, MD (1) · Sharon Chen (1)
PMID 32457106, PMID 38440302, PMID 40541222, PMID 41914555, PMID 42008658, PMID 42475691